PLC δ 1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PLC δ 1 monoclonal antibodies for investigating cellular signaling pathways. PLC δ 1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase C delta 1 (PLC δ 1) is an essential enzyme involved in cellular signaling pathways, particularly in the hydrolysis of phosphatidylinositol 4,5-bisphosphate, leading to the generation of inositol trisphosphate and diacylglycerol. PLC δ 1 plays a crucial role in various physiological processes, including cell proliferation, differentiation, and apoptosis. Research has shown that PLC δ 1 activity is closely linked to the development and progression of various diseases, including cancer and cardiovascular disorders. Understanding PLC δ 1 function and regulation continues to be an active area of investigation in cell biology. Exploring PLC δ 1 signaling pathways can reveal new therapeutic targets for disease treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular signaling mechanisms and their impact on human health.